Epigenetic clocks and biological aging in neurodegeneration

Analysis: SDA-2026-04-01-gap-v2-bc5f270e | Domain: neurodegeneration | Date: 2026-04-01 | 6 hypotheses | 0 KG edges | Autonomous Agent

Hypotheses

#HypothesisTargetScorePrice
#1 TET2-Mediated Demethylation Rejuvenation Therapy TET2 0.588 $0.59
Targeted overexpression of TET2 methylcytosine dioxygenase in specific brain regions can reverse pathological DNA methylation patterns associated with accelerated epigenetic aging in neurodegeneration...
#2 HDAC3-Selective Inhibition for Clock Reset HDAC3 0.574 $0.57
Selective pharmacological inhibition of HDAC3 can reset accelerated epigenetic clocks by restoring histone acetylation patterns at circadian and metabolic regulatory genes....
#3 SIRT6-NAD+ Axis Enhancement Therapy SIRT6 0.460 $0.46
Therapeutic enhancement of the SIRT6-NAD+ pathway through combination treatment with NAD+ precursors and SIRT6 activators can reverse telomere-associated epigenetic aging signatures....
#4 KDM6A-Mediated H3K27me3 Rejuvenation KDM6A 0.422 $0.42
Targeted activation of KDM6A demethylase activity can reverse the accumulation of repressive H3K27me3 marks that characterize accelerated epigenetic aging in neurodegenerative diseases....
#5 FOXO3-Longevity Pathway Epigenetic Reprogramming FOXO3 0.408 $0.41
Targeted reactivation of FOXO3 through demethylation of its promoter region can restore longevity-associated transcriptional programs that become epigenetically silenced during neurodegeneration....
#6 DNMT1-Targeting Antisense Oligonucleotide Reset DNMT1 0.369 $0.37
Brain-penetrant antisense oligonucleotides targeting DNMT1 can selectively reduce pathological hypermethylation at neuronal genes while preserving essential methylation patterns....